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A B S T R A C T
Sample preparation for NMR studies of G protein-coupled receptors faces special requirements: Proteins need to
be stable for prolonged measurements at elevated temperatures, they should ideally be uniformly labeled with
the stable isotopes 13C, 15N, and all carbon-bound protons should be replaced by deuterons. In addition, certain
NMR experiments require protonated methyl groups in the presence of a perdeuterated background. All these
requirements are most easily satisfied when using Escherichia coli as the expression host. Here we describe a
workflow, starting from a temperature-stabilized mutant of the α1B-adrenergic receptor, obtained using the
CHESS methodology, into an even more stable species, in which flexible parts from termini were removed and
the intracellular loop 3 (ICL3) was stabilized against proteolytic cleavage. The yield after purification corre-
sponds to 1–2 mg/L of D2O culture. The final purification step is ligand-affinity chromatography to ensure that
only well-folded ligand-binding protein is isolated. Proper selection of detergent has a remarkable influence on
the quality of NMR spectra. All optimization steps of sequence and detergent are monitored on a small scale by
monitoring the melting temperature and long-term thermal stability to allow for screening of many conditions.
The stabilized mutant of the α1B-adrenergic receptor was additionally incorporated in nanodiscs, but displayed
slightly inferior spectra compared to a sample in detergent micelles. Finally, both [15N,1H]- as well as [13C,1H]-
HSQC spectra are shown highlighting the high quality of the final NMR sample. Importantly, the quality of
[13C,1H]-HSQC spectra indicates that the so prepared receptor could be used for studying side-chain dynamics.
1. Introduction
G protein-coupled receptors (GPCRs) are 7-helix integral membrane
proteins of high pharmacological interest [1]. There are over 800
human GPCRs recognizing a myriad of different ligands and playing a
crucial role in a plethora of cellular processes. Through conformational
changes, GPCRs transduce extracellular stimuli across the membrane to
intracellular effectors such as heterotrimeric G proteins and β-arrestins.
X-ray crystallography has provided structures of GPCRs in ligand-free
apo states, in antagonist- and agonist-bound states, bound to G proteins
and mimics thereof as well as to β-arrestins. This knowledge, which has
been further expanded in recent years by cryo-EM structures of GPCRs
in complex with intracellular effectors, has tremendously enhanced our
understanding of how these receptors function [2,3].
GPCRs sample different conformational states (inactive, inter-
mediate, active), and ligands act on GPCRs by modulating the equili-
brium between these states [4]. Sampling of active states in the ligand-
free form results in receptor basal activity, while agonist binding serves
to shift the equilibrium towards active states [5,6]. Conformational
changes in conserved regions, called micro-switches, dictate the large-
scale helical rearrangements associated with receptor activation and
biased signaling [7,8]. To fully comprehend the mode of action of these
micro-switches, the different states of the receptor must be understood
in molecular detail, including populations, transitions and inter-
conversion rates of different conformations, as well as a further deli-
neation of conformational sub-states. Such a comprehensive picture of
receptor dynamics is difficult to obtain exclusively from crystal-
lography, because the structures represent only snapshots of particular
conformations, and conformations separated by small energy gaps can
be influenced by crystal packing forces. In addition, successfully crys-
tallized GPCRs are often modified by insertion of proteins, such as ly-
sozyme, into flexible loops to provide crystal contacts and usually re-
quire high-affinity inverse agonists to be bound to further rigidify the
structure.
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In principle, solution NMR spectroscopy is capable of quantifying
receptor dynamics at the level of side chain rearrangements using
various flavors of relaxation measurements [9]. Unfortunately, the in-
stability of native receptors precludes measurements at the elevated
temperatures required to obtain NMR spectra of sufficient quality, im-
peding resonance assignment and determination of relaxation rates. In
addition, native receptors typically display very low expression levels,
making it challenging to isolate the milligram amounts of pure and
homogeneous protein required for NMR studies. An important first step
in any GPCR solution-state NMR study is therefore the optimization of
the protein construct to improve expression levels in minimal medium
and to increase thermal stability. To overcome the protein instability
problem, many receptors have been stabilized by introducing point
mutations using alanine scanning mutagenesis or directed evolution, or
through complexation with binders such as nanobodies [10,11].
GPCRs used in crystallographic studies have mostly been produced
in insect cells, but also in mammalian cells, yeast, or E. coli. To assign
proteins of the size of a GPCR using traditional triple-resonance NMR
experiments, uniform 2H, 13C, 15N labeling is required. E. coli is
therefore the preferred host as it allows for culturing in heavy water, in
contrast to insect cells. Alternatively, spectra can be assigned from
point mutants, but this can be laborious, and mutations can often result
in larger changes in the spectra, resulting in ambiguous assignments, or
the point mutants may even alter properties of the protein.
Our work relied on directed evolution to generate thermostabilized
GPCR mutants that can be produced in E. coli and are stable at elevated
temperatures in detergent micelles. Briefly, mutants were generated by
the CHESS method [12], in which E. coli cells expressing a library of
mutants are encapsulated to retain the genotype-phenotype linkage
after solubilization in detergent, followed by selection of stable variants
via binding of a fluorescently-labeled ligand [12].
In this study we describe the production of an NMR sample of a
thermostabilized human α1B-adrenoceptor (α1B-AR). During this study,
the thermal stability of the receptor was further improved and flexible
regions were truncated, resulting in a monomeric receptor construct
that expressed sufficiently well to allow preparation of an NMR sample
(220 μL of 450 μM receptor) from 3 L of culture. Importantly, the GPCR
was stable at 47 °C for weeks in detergent micelles and in phospholipid
nanodiscs. We show how biophysical and chromatographic techniques
were used to guide the optimization process and present 15N- and 13C-
HSQC spectra of the perdeuterated receptor.
2. Results
2.1. Selection of stabilized mutants and construct optimization
The α1B-AR mutant #12, previously obtained by CHESS stabiliza-
tion, was used as the starting variant [13]. This receptor mutant con-
tained 8 amino acid mutations compared to the native human sequence
(Table S1). Some of the initial biophysical characterization described
below was performed on this mutant. Subsequently, N- and C-terminal
truncations as well as an intracellular loop 3 deletion were im-
plemented to avoid degradation by E. coli proteases thereby reducing
the number of mutations to 6. Preliminary tests of this receptor mutant
solubilized in dodecyl maltoside (DDM) revealed insufficient stability at
temperatures desired for measuring triple-resonance NMR spectra for
backbone assignment. Therefore, an additional round of CHESS stabi-
lization was performed. Details of this procedure will be published
elsewhere.
Fig. 1A describes the process that led to the final receptor construct.
Following the initial CHESS stabilization, several mutants were tested
for thermal stability. The most stable mutant, called B1, harbors 14
mutations (Table S1). Analogously to α1B-AR-#12, N- and C-terminal
truncations as well as an intracellular loop (ICL) 3 deletion were im-
plemented, reducing the number of mutations to 13 (Fig. S1).
For expression in E. coli, the genes encoding the receptor constructs
were cloned into a pBR322-derived vector designed by Grisshammer
et al. and modified by Egloff et al. [14,15]. In this vector the receptor is
expressed as a fusion with N-terminal maltose-binding protein (MBP)
and C-terminal thioredoxin A (TrxA) (Fig. 1B). The N-terminal signal
peptide of the MBP moiety results in the secretion of MBP into the
periplasm, and therefore directs the fused GPCR into the E. coli cyto-
plasmic membrane in the correct N-out, C-in topology.
The fusion partners were cleaved off during purification by means of
3C protease cleavage sites, and an additional His- or Avi-tag were in-
serted to allow for additional separations. A schematic representation of
the used constructs is shown in Fig. 1B.
2.2. Optimization of expression
The size of the optimized constructs after removal of the fusion
proteins was ~34 kDa. Triple-resonance experiments for backbone as-
signment of proteins of this size require triply-labeled [2H,13C,15N]
proteins and hence expression in deuterated M9 minimal media.
Optimized expression conditions are therefore crucial for receptors with
low expression yields, in particular when considering the high cost for
isotopically labeled media.
The expression levels were quantified with a radioligand binding
assay (RLBA) using 3H-prazosin as the radioligand. Prazosin is a small-
molecule antagonist which selectively binds to α1-ARs with nanomolar
affinity. Here we only show results obtained with the α1B-AR mutant
#12, which was used for optimization of the conditions, but the mutant
B1 displayed very similar receptors/cell counts (Fig. 2). The highest
expression levels were observed at 30 °C. Expression was quite slow,
and only after 14 h of expression was the maximum number of re-
ceptors/cell observed at 30 °C in light water, which then only slightly
decreased over the next 48 h (data not shown). Interestingly, expression
levels in minimal M9 medium were significantly higher than in the rich
LB or TB media (~20,000 receptors/cell in M9 compared to ~10,000
receptors/cell in LB). However, the final cell mass is typically sig-
nificantly lower in M9 compared to rich media. Further experiments
revealed the limiting effect of glucose and NH4Cl concentrations on the
final optical density at 600 nm (OD600) for overnight growth at 30 °C.
With increased glucose and NH4Cl concentrations, cell masses com-
parable to LB and TB media could be achieved.
The expression in deuterated M9 media was also monitored with a
RLBA. To this end cells were grown in M9 media with 1 g/L NH4Cl and
6 g/L glucose or glycerol. Surprisingly, expression levels were the same
in D2O or H2O when using glucose as the carbon source and only the
final cell density was slightly lower in D2O. The expression in M9 D2O
could be performed with yields comparable to those in M9 H2O. In
contrast, expression levels dropped dramatically in D2O when using
glycerol as the carbon source. Without induction, the cells grown in the
presence of deuterated glycerol reached an even higher OD600 than the
cells grown in the presence of deuterated glucose (data not shown).
Therefore, it seems that expression with glycerol in D2O is inhibiting
cell growth. We suspect that the lac-promoter is more active in the
absence of glucose, and the expression rate is too fast to allow proper
receptor insertion into the E. coli membrane.
According to the RLBA, the amount of functional receptor before
purification was estimated as 4.1 mg per L of M9 culture in case of
expression in D2O with 6 g/L glucose.
2.3. Receptor purification
The α1B-AR constructs were purified using a two-column strategy in
order to obtain homogeneous and pure receptors. Fig. 3 shows the
schematic overview of the two-column strategy.
The cells were lysed with lysozyme and dodecyl maltoside/choles-
teryl hemisuccinate (DDM/CHS). Solubilization with DM or DDM alone
resulted in a lower yield, while the milder lauryl maltose neopentyl
glycol (LMNG) could not effectively solubilize the cells under these
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conditions.
After solubilization, the soluble fraction was incubated with TALON
resin. The receptor construct was selectively bound via its His-tags to
resin-bound Co2+. We observed purer samples using Co2+-TALON resin
compared to Ni2+-NTA. Optimization of the incubation time and the
amount of resin was crucial to maximize binding of the receptor.
Optimal conditions were obtained when using 1 mL of TALON resin per
g of cells and an incubation time of at least 2.5 h.
Detergent was exchanged on the TALON column to LMNG, in which
the receptor was more stable for the subsequent overnight 3C cleavage.
The receptor was eluted from the TALON column with EDTA instead of
imidazole because imidazole proved to be a low-affinity ligand of the
α1B-AR and inhibited binding to the prazosin ligand column.
The second purification step was performed with a prazosin ligand
column (prepared in-house, manuscript in preparation). A cleavable
prazosin derivative was covalently coupled via a protein scaffold to
Sepharose beads in a similar way as described by Egloff et al. [16].
Binding to the column was carried out overnight, simultaneously with
the 3C cleavage. The ligand column possibly exhibits a Kd value similar
to the fluorescently-labeled prazosin derivative BODIPY-FL-prazosin,
also called QAPB (8.5 nM to α1B-AR-#12), as it is modified at the same
site [13]. The receptor can be eluted from the column by competition
with a low-affinity ligand such as imidazole or with a high-affinity li-
gand like prazosin. The latter cannot be removed afterwards, whereas
imidazole can be efficiently removed by desalting and dialysis, allowing
the purification of receptor samples in the apo-state. Removal of the
fusion proteins, 3C protease and the aggregated receptors with this li-
gand column resulted in very pure and homogeneous receptor samples.
Fig. 1. Design of the stabilized α1B-AR construct. A Following CHESS stabilization flexible parts were removed. B Expression constructs showing the location of the N-
terminal maltose-binding protein (MBP) and the C-terminal thioredoxin A (TrxA) fusions, the affinity tags for purification and the 3C cleavage sites. C Snake plot of
the α1B-AR-B1D1 construct, harboring the set of B1 mutations and the ICL3 deletion D1 (Table S1, Fig. S1). Additional linker amino acids and the 3C site are shown in
grey and the 13 mutations in red (one mutation originally selected in the intracellular loop 3 is not shown here as it is in a region deleted in this final construct).
Transmembrane (TM) helices are chosen as predicted by UniProt. (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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The final yield after purification strongly depended on the mutant,
the details of expression and the detergent used. In general, up to 50%
of the receptor estimated by RLBA on cells could be recovered after
purification, which resulted in a yield of up to 2 mg per L of M9 ex-
pression culture in D2O with 6 g/L glucose.
2.4. Loop deletions and truncations of the α1B-AR mutants
We observed degradation in the ICL3 on the SDS-PAGE gel (Fig. S2),
likely by E. coli proteases, and hence we tested deletions within the
ICL3. The loop deletions were already tested with the α1B-AR-#12
mutant and were further transferred to the α1B-AR-B1 mutant, which
was obtained by a second CHESS round from the #12 mutant. Loop
deletion variants are characterized by an additional letter D in their
name from now on, and they are described in Fig. S1.
We monitored stabilizing effects of various ICL3 deletions, as well as
an additional reduction in size. To test thermostability under conditions
more closely resembling those used in the NMR experiments (high re-
ceptor concentrations and high temperatures), the stability was
measured with a SEC-based assay. To this end, the receptor was in-
cubated at concentrations between 50 and 100 μM for multiple days at
a chosen temperature. The stability of the receptor could be deduced
from the change in intensity of the monomeric peak in the SEC chro-
matogram.
Loop deletions D2 and D7 (Fig. S1) showed a significant reduction
in stability at 47 °C, while D1, D4 and D5 were comparably stable (Fig.
S3). To obtain a more homogeneous sample for NMR studies, the re-
ceptor mutant B1 with the ICL3 deletion D1, called α1B-AR-B1D1, was
chosen as the final construct. This α1B-AR construct starts at S35 and
ends at G369 after helix 8, it includes deletion of ICL3 residues
G240–F284 and contains 4 additional N-terminal and 9 C-terminal
amino acids used as linker or belonging to the cleaved 3C cleavage site
(Fig. 1C).
2.5. Characterization of the receptor constructs
The α1B-AR constructs were characterized with different methods to
confirm that the purified receptor samples were pure and monomeric.
The test for ligand-binding capability was already incorporated into the
purification procedure, as the receptor was captured onto a ligand
column and it was eluted by competitive ligand binding.
Reproducible purity was achieved for similar constructs in different
detergents. Samples were usually fairly pure after TALON purification,
and highly pure (> 95%) after the prazosin column (Fig. 4A). The high
purity and the correct receptor mass were further confirmed via ESI-MS.
Higher cone energies helped to remove bound LMNG moieties with
additional masses of 1005 Da (Fig. 4B).
The stability of the receptor mutant was also analyzed with a 7-
diethylamino-3-(4′-maleimidylphenyl)-4-methylcoumarin (CPM) assay
[17]. Therein, thermal unfolding is monitored by the increase in
fluorescence of the CPM dye upon binding to cysteines and hydro-
phobic patches exposed during protein denaturation [18]. Fig. 4D
shows that the α1B-AR-B1 receptor construct has an apparent Tm of
76 °C in DDM/CHS, indicating an exceptionally high stability compared
to other GPCRs measured under similar conditions [19].
The Kd values for the wild-type (wt) α1B-AR receptor as well as for
the B1 and #12 mutants were determined using a RLBA. We de-
termined a value of 0.07 nM for the wt receptor, 0.80 nM for the B1
mutant and 1.18 nM for the #12 mutant (Fig. 4C). The affinity of
prazosin for the mutant α1B-AR proteins is thus still very strong.
The homogeneity of the α1B-AR constructs was also analyzed by SEC
on a Superdex 200 column (Fig. 5). After the ligand-affinity column
purification the receptor showed a very homogeneous peak. We applied
multi-angle-light-scattering (MALS) coupled to SEC to determine the
absolute mass of the receptor in detergent micelles. Two detectors,
capable of determining the concentration (UV and refractive index, RI),
allow to deconvolute the total mass into the masses of the protein and
of the detergent micelle. Thereby, MALS allows determination of the
oligomeric state of the protein in the detergent micelles. For the de-
tergents, the dn/dc values were determined with a calibration curve.
For DDM/CHS, a value of 0.1569 ± 0.0035 mL/g was measured, close
to the published value [20], while for LMNG a value of
0.1382 ± 0.0010 mL/g was determined. Together with the standard
dn/dc value for proteins of 0.185 mL/g, the composition of the protein/
micelle complex can be determined.
An accurate measurement was performed with the α1B-AR-#12D2
construct in DDM/CHS (10:1 w/w) and in LMNG (Fig. 5). For the re-
ceptor in DDM/CHS a calculated protein mass of 31.5 kDa fits well to
the expected molecular weight of 34.4 kDa, clearly revealing that the
receptor was monomeric in the micelle. The empty DDM/CHS micelle
had a mass of 84 kDa, while in complex with the protein the mass of the
detergent was 123.2 kDa, leading to a total protein-detergent mass of
154.7 kDa. In case of the receptor in LMNG detergent, the empty mi-
celle had a calculated mass of 87.8 kDa, while with the receptor the
detergent micelle had a mass of 101.2 kDa, and the whole detergent-
Fig. 2. Optimization of growth and expression conditions. A Receptors per cell
count from RLBAs when varying temperature and medium composition. Error
bars indicate the standard deviation of triplicates. B Final OD600 after overnight
growth of BL21 cells at 30 °C with varying amounts of glucose and NH4Cl. C
Comparison of final OD600 and receptors/cell after expression in light and
heavy water using different carbon sources.
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Fig. 3. Schematic overview of the purification strategy. A The receptor is extracted from the E. coli membrane and solubilized in DDM/CHS micelles. Subsequently,
immobilized metal ion affinity chromatography (IMAC) is used to separate the receptor construct from contaminants, after which the fusion proteins are removed. A
final purification step involves binding to a ligand column (prazosin column). B The receptor can be either eluted with molar excess of a high-affinity ligand like
prazosin or with a high concentration of a low-affinity ligand like imidazole, which can subsequently be removed by dialysis to obtain apo-state receptor.
Fig. 4. Characterization of the α1B-AR-B1D1 mutant. A SDS-PAGE gel of the α1B-AR-B1D1 mutant purified in LMNG. B ESI-MS of the α1B-AR-B1 mutant. C Kd values
of prazosin for the wild-type (wt) α1B-AR, the B1 and #12 mutants. D CPM assay of the α1B-AR-B1 mutant in DDM/CHS with prazosin bound.
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protein complex was 138.1 kDa. The protein mass was determined as
36.9 kDa, again in agreement with the expected mass of a monomer.
Interestingly, even if the difference in mass between the LMNG and
DDM/CHS samples is not very large for both the empty micelles and the
protein-detergent complexes, the longer elution times on the gel fil-
tration column indicate that the hydrodynamic radius of the LMNG
micelles is smaller.
2.6. Optimizing the choice of detergent
The choice of the optimal detergent is often the most crucial step for
successful NMR experiments. Typically, during purification and for
functional assays, stabilizing detergents forming large micelles like
DDM/CHS are preferred. For solution NMR, however, the size of the
protein-detergent complex matters, as a smaller size leads to longer T2
relaxation times and thus sharper peaks. Conversely, smaller detergents
may intercalate in the membrane protein and thus help unfold it.
An initial screen to test multiple detergents in parallel was per-
formed with a fluorescence-based assay with biotinylated receptor and
streptavidin-coated magnetic beads. The α1B-AR-#12-Avi construct,
biotinylated at its C-terminus, was solubilized in DM, immobilized on
magnetic beads and saturated with BODIPY-FL-prazosin. The receptor,
bound to the magnetic beads, was then exposed to buffers containing
different detergents at 4 °C. After incubation in the presence of BODIPY-
FL-prazosin for 1 h at 37 °C or 24 h at 37 °C, the beads were washed and
the remaining fluorescence signal was measured, corresponding to li-
gand molecules bound to functional receptor molecules (Fig. 6A).
Many detergents already caused precipitation after incubation for
1 h at 37 °C (e.g. in DPC, DH7PC or LDAO). The highest remaining
fluorescence was obtained in DDM and DDM/CHS. A stabilizing effect
of CHS was clearly detected when comparing DM/CHS to DM.
Measurements after 24 h revealed that a number of other detergents
such as LMPC, Tween-20 and DM/CHS did not provide sufficient long-
term stability at 37 °C. In general, the maltosides provided the highest
stability. The best results were obtained when using LMNG and LMNG/
CHS, for which ligand binding was retained even after 24 h at 37 °C.
The lower absolute fluorescence levels compared to DDM and DDM/
CHS were possibly due to the higher background fluorescence observed
in LMNG. It appears, therefore, that LMNG is a well-suited detergent to
Fig. 5. SEC-MALS diagram of α1B-AR-#12D2. A Data in DDM/CHS. B Data in
LMNG. Depicted are the UV, RI and LS detector data (in green, blue and red,
respectively). The lines in black, orange and purple indicate the mass of the
complex, the detergent and the protein, respectively. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web
version of this article.)
Fig. 6. Stability and size of α1B-AR mutants in different detergents. A Measured
fluorescence of BODIPY-FL-prazosin bound to the α1B-AR-#12-Avi construct in
different detergents after 1 h of incubation at 37 °C (dark grey bars) and after
24 h of incubation at 37 °C (light grey bars). Error bars indicate the standard
deviation of the measured triplicates. B SEC profiles of α1B-AR-B1 (carrying no
ICL3 deletion) in different detergents. C SEC profiles of α1B-AR-B1D1-His in
different detergents and lipid nanodiscs.
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stabilize the receptor for a sufficiently long period of time at high
temperatures.
The effect of changes in pH (screened between 6.5 and 8.0) and salt
concentration (10 mM – 600 mM), tested in a similar assay with the
receptor solubilized in DM at 4 °C, revealed no differences in receptor
stability under the different buffer compositions (Fig. S4).
To find out which detergents were most suitable for NMR experi-
ments, a variety of detergents were evaluated with regards to the size of
the protein-detergent complex (using SEC), yields of purified protein
and long-term thermostability (Fig. 7). To this end, the B1D1 receptor
construct was solubilized and purified in DDM/CHS, followed by ex-
change to the detergent of choice on the ligand-affinity column.
Fig. 6BC displays SEC chromatograms for different detergents such
as common maltosides like DDM and DM, and neopentyl glycosides like
LMNG, UDMNG and DMNG. Noteworthy, the addition of CHS to the
detergent in a 1:10 weight ratio always increased the size of the mi-
celles, while reducing the hydrophobic chain length made the micelles
smaller.
LMNG leads to a relatively small size of the protein-detergent
complex and very good long-term stability. Because of the intended use
in NMR, only detergents that resulted in small protein-micelle com-
plexes, comparable to LMNG or smaller, were tested for long-term
stability. In DMNG the receptor could be purified in good yields but
aggregated after incubation for 3 days at 47 °C, even in the presence of
CHS. In DH7PC, the yields after receptor purification were very low,
and the corresponding peak in SEC was broad, and no active receptor
remained after 1 day at 37 °C. In UDMNG, the receptor displayed almost
comparable stability as in LMNG. However, the size-difference was only
minor and LMNG still displayed superior stability. Therefore, LMNG
was the detergent of choice moving forward. Compared to the mutant
#12, the stability of mutant B1 was significantly higher. After 15 days
at 47 °C almost no aggregation was visible, while> 50% of mutant #12
was aggregated. Importantly, this high stability could only be achieved
in the prazosin-bound state, while the apo state sustained well only
temperatures up to 22 °C.
2.7. Incorporation into lipid nanodiscs
Detergents are artificial membrane mimetics that do not fully reflect
the lipid bilayer, especially when they have very short alkyl chains.
Lipid nanodiscs, on the other hand, represent a more natural environ-
ment for solubilizing membrane proteins, since they form planar bi-
layers. Nanodiscs are composed of two copies of a membrane scaffold
protein (MSP), which are wrapped around a lipid bilayer, forming small
disk-shaped objects. By changing the length of the MSP, disks of dif-
ferent sizes are obtained. This technique was developed by Sligar et al.
[21], and MSP constructs yielding smaller nanodiscs were developed by
Hagn et al. [22]. In our hands, best results were obtained with the
MSPΔH5 construct and the circularized version, the cNW9 [23], where
the N- and C-termini are covalently fused using sortase-mediated liga-
tion.
To incorporate the receptor into the nanodiscs, a mixture of de-
tergent-solubilized receptor, detergent-solubilized lipids and MSP was
incubated at a chosen temperature. The detergent was removed with
BioBeads, triggering formation of the receptor-nanodiscs complexes,
provided that an optimal lipid:MSP:receptor ratio was achieved.
Many different conditions were screened for receptor incorporation
into nanodiscs. The receptor was purified in different detergents such as
DM, DDM, and LMNG, and incorporation was tested for different lipids
(DMPC, DMPG, POPC and POPG) at different temperatures, ratios and
amounts of BioBeads. Finally, one condition was identified that allowed
incorporation yields of approximately 78%. The optimized protocol
used the lipid mixture DMPC:DMPG in a 3:2 molar ratio solubilized in
Na-cholate, the receptor solubilized in a low concentration of LMNG
(~0.02%), an incubation temperature of 25 °C and a
receptor:MPSΔH5:lipid molar ratio of 1:8:400 (or 1:8:480 for cNW9).
The same protocol was also successful for a lipid mixture containing
CHS in a ratio DMPC:DMPG:CHS of 3:2:1.
Fig. 7. SEC profiles of α1B-AR receptor mutants in different membrane mimetics. The receptor was always incubated in the presence of prazosin if not mentioned
otherwise. Depicted are data before and after incubation at different timepoints and temperatures.
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The incorporation of the α1B-AR into the circularized version of the
scaffold protein used the same protocol and resulted in similar yields.
After incorporation and purification, the scaffold protein and the re-
ceptor could both be detected on the SDS-PAGE gel (Fig. S5) and
showed a single peak with the expected size on the SEC chromatogram.
The long-term stability was tested at 47 °C for both nanodisc samples,
showing a slightly better stability in the cNW9 nanodiscs. However, in
comparison to LMNG micelles the long-term stability in the nanodiscs
was slightly inferior (Fig. 7).
NMR spectra could be measured for the α1B-AR-B1D1-His construct,
since the receptor-nanodisc assemblies could be separated from the
empty nanodiscs by His-trap pulldown. Removal of empty nanodiscs
was crucial because too high concentrations of empty nanodiscs re-
sulted in complete sample aggregation at higher temperatures.
Incorporation with high yields could only be achieved with the pra-
zosin-bound receptor and not with the significantly less stable apo-state
receptor.
2.8. Initial NMR experiments
The quality of NMR spectra is of prime importance to allow suc-
cessful assignments. It is a common experience that spectra of helical
membrane proteins display inferior quality when compared to those of
well-behaved soluble proteins. The detergent micelle or lipid nanodiscs
add to the apparent molecular weight of the protein slowing down
tumbling rates, and hence even rigid membrane proteins display
broader lines than soluble proteins of comparable size. The effects of
transverse relaxation can be somewhat reduced by perdeuteration that
serves to dilute protons and thereby removes many sources of dipolar
interaction. A representative [15N,1H]-TROSY spectrum of the α1B-AR-
B1D1 in LMNG micelles is depicted in Fig. 8.
In general, line-shapes and peak intensities are of reasonable to
good quality. However, some signals display unusual line-shapes, in-
dicating the presence of more than one conformation. A count of the
peaks, however, immediately reveals that too few signals are observed
in the [15N,1H]-TROSY spectrum of the α1B-AR construct.
The missing peaks could be absent because they may be broadened
beyond detection by conformational exchange processes. 7-TM pro-
teins, and in particular GPCRs, populate various states, and transitions
between these occur frequently as part of their biological function.
Stabilizing the inactive state by directed evolution and by binding to a
high-affinity antagonist (prazosin), however, should have reduced
conformational exchange processes.
Another explanation for the missing peaks is a lack of back-ex-
change of amide deuterons to protons. Triple-resonance 3D NMR
spectra of helical membrane proteins require perdeuterated samples to
reduce transverse relaxation to tolerable levels. Especially the Cα needs
to be fully deuterated to allow experiments involving transfer steps or
chemical shift labeling of Cα. Deuteration is usually obtained by ex-
pressing in deuterated water, and hence all amide protons are replaced
by deuterons as well and need to be exchanged back to protons during
purification. Unfortunately, water never gains access to most amides of
the TM helices, and therefore amide deuterons cannot easily be ex-
changed back to detectable protons. In principle, this problem could be
circumvented if the protein is unfolded and then refolded, which
however proved so far to be impossible for the α1B-AR.
To verify that the missing peaks were indeed due to the lack of back-
exchange, the α1B-AR-B1D1 construct was expressed in light water, and
a spectrum of a highly concentrated sample was compared to the
spectrum recorded with a sample expressed in deuterated water
(Fig. 8). Peaks in the protonated spectra are broader and hence weaker
than in the deuterated sample, but many additional peaks appeared. To
verify the hypothesis that the lack of some peaks in the deuterated
sample is due to missing back-exchange, the buffer of the protonated
sample was exchanged to a pure D2O buffer. Fig. 8 demonstrates that
the additional peaks in the sample that stem from expression in light
water did not disappear in the D2O buffer. This was a clear indication
that these amide protons are protected from water access. Interestingly,
after recording 3D spectra for many days at 47 °C some additional peaks
appeared in the 2D spectra, likely from amides with very slow exchange
with water.
In addition, we also recorded [15N,1H]-TROSY spectra of the α1B-
AR-B1D1-His construct in DMPG/DMPC nanodiscs (Fig. 9). The quality
of the spectrum in the smaller LMNG micelle is significantly better than
the corresponding one in the nanodiscs. The 15Ne1H correlation spectra
are different, which is not surprising, considering that only water-ac-
cessible parts can be seen. These regions are likely in contact or close to
the headgroup of the detergent or the lipid, and therefore have a dif-
ferent chemical environment.
The detection of methyl groups in [13C,1H]-HSQC spectra is much
more sensitive than detection of amide moieties in the corresponding
15N-correlated spectra due to the rotation of the methyl group about its
symmetry axis, and the fact that there are three homotopic protons. The
methyl spectra in LMNG and nanodiscs look more similar and all ex-
pected peaks are likely visible, because they do not suffer from the lack
of back exchange. Since methyl groups rarely face the lipid headgroups,
differences between nanodiscs and detergent micelles are smaller and
peaks in general shift only slightly. It should be kept in mind that dif-
ferent chemical shifts could arise from a different distribution of con-
formations of the receptor in nanodiscs and in detergent micelles as
reported from Kofuku et al. [24].
Fig. 8. Heteronuclear NMR spectra of the α1B-AR-B1D1 in LMNG. A [
15N,1H]-
TROSY of 300 μM deuterated α1B-AR-B1D1. B: Expansion of the [
15N,1H]-
TROSY spectra of the receptor expressed in D2O (black; 250 μM) and in H2O
(red; 400 μM). Blue contours shows the protonated sample after exchange to
pure D2O buffer. All spectra were recorded at 700 MHz, 47 °C. (For inter-
pretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
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3. Discussion
Understanding the dynamics of GPCRs is of prime importance to
fully comprehend the molecular processes by which these receptors
function. X-ray crystallography and cryo-EM have provided much mo-
lecular detail describing structures of GPCRs in various states and in
complex with signaling partners [2], but these represent frozen snap-
shots of certain states. Since it is well established that GPCRs populate
multiple states, interconversion between these populations are funda-
mental for receptor activation [4]. In principle, solution NMR is a
technique suitable to analyze these dynamical processes, but problems
arise in obtaining spectra of sufficient quality to allow assignment of the
corresponding peaks. In recent years, many NMR studies performed on
GPCRs focused on specific aspects of receptor activation or interaction
with ligands, G proteins or arrestins [25]. Whether it is structure cal-
culations, chemical shift perturbations or determination of dynamics,
chemical shift assignments are usually the first step in the analysis.
When using proteins of the size of a GPCR, assignment methods that are
not based on mutagenesis require samples with high deuteration of non-
labile protons, and often methyl-protonated proteins in fully perdeut-
erated background are particularly useful. The best host to accomplish
such labeling patterns is currently E. coli.
Unfortunately, GPCRs generally do not express well in E. coli, a host
for which uniform 15N and 13C labeling strategies as well as the im-
portant deuteration are well established. Therefore, expression has been
usually performed in insect cells, and only a certain type of amino acid
was selectively labeled, for example with 19F probes attached to
cysteines [26,27] or 13CH3-Met [28–30] and assigned by mutagenesis
[31]. These sensitive probes give useful spectra even without perdeu-
teration, albeit only at individual positions. The β1-AR and the β2-AR
could be labeled with 15N-Val and 15N-Leu, respectively. Assignments
were obtained by point mutations and chemical shift perturbations
could be measured [32]. Nevertheless, three receptors have been ex-
pressed in E. coli for NMR measurements. The BLT2 receptor was ex-
pressed as inclusion bodies in E. coli and could successfully be refolded
into nanodiscs [33]. In addition, NTR1 stabilized by CHESS and thus
expressible as a functional protein in E. coli was investigated [23,34]. In
a recent NMR study a highly stabilized version of the α1A-AR was
modified to enable signaling, and expressed in E. coli with 13CH3-me-
thionine labeling [31]. An elegant way of combining E. coli expression
with insect cell expression was shown by Shiraishi et al. [35], where the
C-terminal portion following helix 8 of the β2-AR was expressed and
labeled in E. coli and then fused through protein trans-splicing to a
13CH3-Met labeled receptor that was produced in insect cells. Methods
that use insect or mammalian cells unfortunately significantly restrict
the tools for isotope-labeling [36]. Presently, a severe disadvantage is
the fact that ILV methyl labeling in perdeuterated background is im-
possible because these cells cannot be grown in deuterated water and
the established ILV precursors are not metabolized in these cells. The
measurement of methyl dynamics, however, strictly requires almost
complete absence of protons proximal to the methyl groups, and this is
most conveniently achieved in E. coli. Nonetheless, P. pastoris is a eu-
karyotic host which allows deuteration. In these cells, the adenosine
A2A receptor was expressed with a deuteration level of 70% and even
13CH3-Ile groups could be labeled with precursors [37,38].
To achieve a more extensive assignment and to probe the entire
receptor by NMR, we uniformly labeled the GPCR and attempted to
assign the peaks using standard triple-resonance NMR spectra. To
overcome the low yields of heterologous expression of most wild-type
GPCRs in E. coli, we used a directed evolution mutagenesis approach
(CHESS method) [9] to obtain a well-expressing and stabilized mutant.
Furthermore, we tested and analyzed many conditions to obtain a
sample with the properties suitable for measuring 3D NMR spectra.
So far, the only 7-helical membrane protein structures determined
by solution NMR techniques were proteorhodopsin [39] and sensory-
rhodopsin [40], two microbial rhodopsins, which were both expressed
in E. coli and solubilized in DH7PC. In both cases extensive backbone
and methyl assignments were made and good-quality structures were
computed from NOEs and paramagnetic relaxation enhancement (PRE)
probes. However, even with our stabilized GPCR mutant, we realized
that the stability in the short-chain detergent DH7PC was not sufficient
to record NMR spectra over extended periods of time at elevated tem-
peratures, and therefore, we had to use milder detergents which result
in larger micelles. Recently, we could demonstrate that 62% of the
backbone of bacteriorhodopsin can be assigned in large systems such as
nanodiscs, indicating that the size of such proteins per se is not pro-
hibitively large [41]. The quality of NMR spectra for the α1B-AR in-
corporated into nanodiscs was unfortunately significantly inferior
compared to samples in LMNG micelles, which, nonetheless, could be
due to the increased size.
GPCRs are intrinsically dynamic proteins — they populate multiple
conformations belonging to different activation states, and addition of
ligands typically redistributes these populations. Thermostabilizing the
receptors likely alters those dynamics, which makes many of them ac-
cessible to structural studies in the first place, as only extremely few
natural ones intrinsically have the necessary stability. Nonetheless,
great care must be taken to avoid overinterpretation by taking into
account the likely changes in dynamics and redistribution of popula-
tions. Therefore, it is important to verify that the receptor mutant still
has wild-type like behavior. In the end, most GPCRs cannot be in-
vestigated by NMR without addition of mutations or modifications. An
exception is the adenosine A2A receptor which seems to be a naturally
more well-behaving receptor, and therefore NMR studies could be
Fig. 9. Comparison of heteronuclear NMR spectra of α1BAR-B1D1 in LMNG
micelles and α1BAR-B1D1-His in nanodiscs. A [
15N,1H]-TROSY of 180 μM
B1D1-His in nanodiscs and 250 μM B1D1 in LMNG. B [13C,1H]-HSQC of 180 μM
B1D1-His in nanodiscs and 300 μM B1D1 in LMNG. Spectra were recorded at
700 MHz, 47 °C.
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carried out with a construct that contained no thermostabilizing mu-
tations [26,37,38,42–46]. The investigated β1-AR constructs usually
contained a variety of different thermostabilizing mutations
[29,32,45,47–49]. While the investigated β2-AR variants in general
contained fewer thermostabilizing mutations, they usually had muta-
tions to reduce the number of Cys or Met residues [24,27,28,33,50–54].
In summary, most of the studied GPCRs have been optimized by mu-
tations. We are convinced that a large fraction of GPCRs will only be-
come amenable to detailed biophysical analysis once they are suitably
stabilized. Our approach, starting with highly stabilized versions and
subsequently removing some of these mutations to recover activity,
presents a rational approach that is a powerful alternative to the pre-
sently used methods. The used α1B-AR-B1 mutant did not show any
signaling in an IP1-based signaling assay (data not shown) [55].
However, this receptor mutant helped to establish a protocol for the
expression and purification, to optimize NMR experiments and to ob-
tain initial assignments. In an ongoing study we recently obtained a
stable and signaling-competent α1B-AR receptor mutant (data not
shown), which would not have been possible without the initial B1
mutant. In a similar approach, conformational changes observed in a
signaling-incompetent α1A-AR mutant, which could be used for estab-
lishing all expression and NMR methods, were essentially retained in
the signaling-competent receptor [31], suggesting that the study of such
stabilized mutants is very valuable.
An important remaining issue for the NMR analysis is the absence of
amide peaks from the TM portions due to the lack of amide-proton
back-exchange. So far, we were unable to develop conditions that lead
to the back-exchange of these amide protons in the hydrophobic core.
Amide protons are crucial for structure determinations because they
serve as anchoring points for the sequential backbone assignment with
3D-spectra. Fortunately, E. coli, in contrast to eukaryotic expression
hosts, allows production of perdeuterated proteins that incorporate
fully protonated methyl groups, the so-called ILV labeling [56,57].
These methyl groups are ubiquitous in membrane proteins, in the α1B-
AR-B1 construct about one third of all amino acids. Experiments to use
these probes for measuring side chain dynamics in membrane proteins
have been developed that are tailored to this labeling pattern [9,58,59]
but require absence of protons in the proximity of the methyl group.
Methyl-based signals are detected much more sensitively than their
amide-based counterparts. Our previous assignment of methyl groups in
bacteriorhodopsin was heavily based on assigned backbone amides.
However, it might be possible to assign the majority of the methyl
groups with a 4D-NOESY and the help of an existing structure or a
structure model and a few mutations. To obtain a high quality 4D-
NOESY spectrum the receptor as well as the membrane mimetics need
to be highly deuterated. The signal overlap, as apparent in Fig. 9B, can
be drastically decreased if the spectra are recorded on a high field
spectrometer (≥900 MHz) and when using precursors for stereospecific
labeling [57] (Fig. S6). A few mutations as anchoring points may still be
required, but we believe that the required number of these is still much
lower than for the so-far-used full mutagenesis approaches that are
needed for GPCRs expressed in eukaryotic cells. We therefore anticipate
that expression of GPCRs in E. coli will provide a useful avenue for
obtaining these long-sought dynamics data.
4. Methods
4.1. Cloning
Receptor constructs were ordered as gBlock gene fragments (IDT)
and cloned into the pRG (pBR322-derived) vector, with an N-terminal
MBP and a C-terminal TrxA fusion, using the restriction enzymes
BamHI and XmaI.
4.2. Expression
Competent E. coli BL21 cells (C2530, New England Biolabs) were
transformed and selected on LB-agar containing 1% D(+)-glucose and
100 mg/L carbenicillin. A preculture from a single clone was grown in
M9 H2O media (3 g/L KH2PO4, 7.5 g/L Na2HPO4 · 2 H2O, 0.5 g/L NaCl,
2 mM MgSO4, 100 mg/L ampicillin, 1 mL/L 1000× trace metals (for
composition see SI Supplementary Methods), 1.5 g/L [15N]-NH4Cl, 7 g/
L D(+)-glucose, 100 mg/L yeast extract). For the expression in H2O the
main culture consisted of the same media without the yeast extract. At
an OD600 = 0.8, the cells were induced with 0.5 mM IPTG (final con-
centration) and the expression was continued at 30 °C for 14–20 h.
For expression in deuterated media, a second preculture in M9 D2O
(3 g/L KH2PO4, 6 g/L Na2HPO4, 0.5 g/L NaCl, 2 mM MgSO4, 100 mg/L
ampicillin, 1 mL/L 1000× trace metals, 1.2 g/L [15N]-ND4Cl, 3.5 g/L D
(+)-glucose-1,2,3,4,5,6,6-d7) was inoculated from the M9 H2O pre-
culture. Receptor expression in the M9 D2O main culture was as de-
scribed above.
For the ILV labeling, the following precursors from Cambridge
Isotope Laboratories were added 1 h before induction: 70 mg/L alpha-
ketobutyric acid, sodium salt (methyl-13C, 99%; 3,3-D2, 98%) and
160 mg/L alpha-ketoisovaleric acid, sodium salt (3-methyl-13C, 99%;
3,4′,4′,4′-D4, 98%).
For the stereoselective ILVproS labelling, the following precursors
from NMR-Bio were added according to the manufacturer's instructions:
1 h before induction 2-hydroxy-2-[2′-13C,1H-1′-D2]ethyl-3-oxo-4[D3]




The purification was performed at 4 °C with precooled buffers. Cells
were resuspended in 7.5 mL/g pellet of 50 mM HEPES pH 8, 200 mM
NaCl, 10% glycerol, 15 mM imidazole, 2 mg/mL lysozyme, 0.05 mg/mL
of DNase and 5 mM MgCl2. A mixture of 10% (w/v) n-dodecyl-β-D-
maltopyranoside (DDM, Anatrace) and 1% (w/v) cholesteryl hemi-
succinate (CHS, Sigma-Aldrich) was added to a final concentration of
2% DDM / 0.2% CHS and solubilization was continued for 2 h with
stirring. The lysate was centrifuged for 30 min at 18,000 rpm in a SS34
rotor. The supernatant was incubated with TALON Superflow resin (GE
Healthcare) equilibrated with TWB1 (25 mM HEPES pH 8, 600 mM
NaCl, 10% glycerol, 0.075% lauryl maltose neopentyl glycol (LMNG,
Anatrace), 15 mM imidazole). Per 1 g of cells 1 mL of TALON resin was
used and the binding was continued for 2.5 h with gentle rolling.
Washing was performed in PD10 columns with a column volume (CV)
of 2.5 mL TALON resin. The columns were washed 4 times with 4 CV of
TWB1 and 4 times with 4 CV of TWB2 (25 mM HEPES pH 7, 150 mM
NaCl, 10% glycerol, 0.05% LMNG). The protein was eluted with 3 CV of
TEB (25 mM HEPES pH 8, 150 mM NaCl, 10% glycerol, 0.05% LMNG,
200 mM EDTA). 1 mg of 3C protease was added per 15 mL of elution
and incubated for 30 min. Per 5 g of cells 0.5 mL of prazosin column
(PC) resin equilibrated in TEB was added and incubated overnight. The
resin was subsequently transferred into an empty PD10 or a 2 mL Bio-
Rad column and was washed 3 times with 2 CV of PCWB1 (25 mM
HEPES pH 8, 600 mM NaCl, 10% glycerol, 0.025% LMNG, 200 mM
EDTA) and 3 times with 2 CV of PCWB2 (20 mM Na-Phosphate pH 7,
20 mM NaCl, 0.01% LMNG). 4.5 CV of PCEB (10 mM Na-phosphate
pH 7, 20 mM NaCl, 0.01% LMNG, 85 μM prazosin (Sigma-Aldrich)) was
added to the column and incubated while rolling for 2 h. The flow-
through as well as a wash with two times 1 CV of PCEB were collected.
The final protein sample was obtained by concentrating the PC elution
using an Amicon Ultra-4 (50 kDa molecular weight cut-off).
In order to determine the protein concentration, excess prazosin had
to be removed. To this end, an analytical fraction of the final sample
was loaded onto a Zeba Spin desalting column (7 kDa molecular weight
cut-off, Thermo Fisher Scientific) equilibrated with 10 mM Na-
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phosphate pH 7, 100 mM NaCl, 0.01% LMNG, 2.5 μM prazosin.
Absorption at 280 nm was measured using a Nanodrop spectro-
photometer and it was corrected with an empirically determined cor-
rection factor of 0.7 to take into account absorption of receptor-bound
prazosin.
To obtain the apo receptor, elution from the PC was performed in
10 mM Na-phosphate pH 7, 20 mM NaCl, 0.01% LMNG, 350 mM
imidazole. Imidazole was then removed with a PD-10 desalting column
(GE Healthcare) and by dialysis in a 10 mL Float-A-Lyzer (Spectrum)
with a 10 kDa molecular weight cut off against 500 mL of 10 mM Na-
phosphate pH 7, 20 mM NaCl, 0.01% LMNG.
4.4. Reconstitution of α1B-AR into nanodiscs
Deuterated lipids d54-DMPC and d54-DMPG (from FB reagents) were
solubilized at 50 mM in Lipid buffer (20 mM HEPES pH 8, 100 mM Na-
cholate) at 47 °C and a lipid mix of DMPC:DMPG at a molar ratio of 3:2
was prepared. The purified constructs α1B-AR-B1D1-His at 2 mg/mL in
LMNG, MSPΔH5 at 3.5 mg/mL and the lipid mix were mixed in a molar
ratio of 1:8:400 (or 1:8:480 for cNW9) and incubated overnight at 25 °C
and 600 rpm. 0.5 g/mL prewarmed BioBeads SM-2 (Bio-Rad) were
added to the mix and incubated for 4 h at 25 °C with slight shaking. The
BioBeads were removed by filtration and washed two times with 5 mL
of α1B Nanodisc buffer (20 mM Tris pH 8 at RT, 100 mM NaCl, 10 μM
prazosin). The flow-through was collected and prazosin was added to a
final concentration of 20 μM. The nanodisc solution was loaded on a
1 mL HisTrap HP column (GE Healthcare) and washed with α1B
Nanodisc buffer. The α1B-AR nanodiscs were eluted with 20 mM Tris
pH 8, 100 mM NaCl, 300 mM imidazole, 20 μM prazosin. The elution
was buffer-exchanged with a PD-10 desalting column to 10 mM Na-
phosphate pH 7, 20 mM NaCl, 10 μM prazosin and subsequently con-
centrated to 200 μL using an Amicon Ultra-4 (50 kDa molecular weight
cut-off). Additional information for the purification of MSPΔH5 and
cNW9 is described in the SI.
4.5. SDS-PAGE
The protein samples were analyzed on 8–16% ExpressPlus PAGE
Gels (GenScript) with 1× Tris-MOPS buffer (50 mM Tris, 50 mM MOPS
0.1% SDS, 1 mM EDTA) in a Biorad electrophoresis system. 20 μL of the
protein sample was mixed with 6.6 μL 4× SDS loading buffer (200 mM
Tris pH 6.8, 400 mM DTT, 8% SDS, 0.4% bromophenol blue, 40%
glycerol) and stored at −20 °C until further use. The samples were not
heated up prior to loading because heating the samples led to laddering
of the receptor on the gel. The gel was run for 45 min at 140 V.
Afterwards, the gel was stained for 15–60 min with staining buffer
(40% methanol, 10% acetic acid, 2.4 g/L Coomassie brilliant blue R-
250). The background was destained 2–3 times with destaining buffer
(40% methanol, 10% acetic acid) for 15–30 min. The gel was imaged
using a Biorad ChemiDoc MP imaging system.
4.6. Fluorescent ligand-based stability assay
20 g of cells after expression were resuspended in 80 mL of PBS and
10 mL aliquots were stored at−80 °C. One aliquot was mixed with the
same volume of PBS pH 7.4, 4 mg/mL lysozyme, 0.2 mg/mL DNase,
1 mM EDTA, 1 tablet of Roche cOmplete mini protease inhibitors, 4%
DM and 0.8 μM BODIPY-FL-prazosin. For the background control, an-
other aliquot was mixed with the same buffer supplemented with
0.2 mM prazosin. Both aliquots were incubated for 2 h at 4 °C while
rotating. Cell debris was pelleted with a Fiberlite SLA600TC rotor at
13,000 rpm for 30 min at 4 °C. 500 μL Streptavidin-coupled Dynabeads
were added to the supernatant and incubated for 1 h at 4 °C. 200 μL of
the Dynabeads suspension was added to each well of a KingFisher 96
well-plate. The beads were washed 2 times with a KingFisher robot in
300 μL of 50 mM Na-phosphate pH 7.4 supplemented with either one of
the following detergents: DPC 5 mM, LMPC 1 mM, LMPG 1 mM, LPPG
1 mM, DH6PC 30 mM, DH7PC 4 mM, LMNG 0.01%, LMNG/CHS 0.01/
0.001%, DDM 0.1%, DDM/CHS 0.1/0.01%, DM 0.5%, DM/CHS 0.5/
0.05%, LDAO 5 mM, Tween20 0.02%. The beads were transferred in
140 μL of the detergent buffer containing either 0.25 μM BODIPY-FL-
prazosin or an additional 12.5 μM prazosin for the background control.
Two plates with the same conditions were prepared and sealed. One
was incubated for 1 h and the other for 24 h at 37 °C while shaking at
1000 rpm. After the incubation, the beads were washed again 2 times in
300 μL of the corresponding detergent buffer and transferred in 120 μL
thereof. 100 μL of the suspension was transferred in a black 96-well
plate on ice and the fluorescence was measured (excitation 458 nm,
emission 520 nm).
4.7. Radioligand binding assay
After expression, 100 μL aliquots of bacterial culture were pelleted
for 10 min at 10,000 ×g at room temperature. The supernatant was
carefully removed, and the cell pellets were flash-frozen in liquid ni-
trogen and stored at −80 °C.
The samples were resuspended in Wash buffer (50 mM Tris-HCl
pH 7.4) to an OD600 of 1. In a 96-well plate, 20 μL of the cell suspension
was added to 160 μL of binding buffer (50 mM Tris-HCl pH 7.4, 1 mM
EDTA pH 8, 40 μg/mL Bacitracin, 0.1% (w/v) BSA, 20 nM 3H-prazosin
(PerkinElmer) or binding buffer supplemented with 40 μM prazosin.
The plate was closed with an adhesive seal and incubated for 2–3 h at
4 °C while shaking. Meanwhile, a 96-well filter plate was incubated
with 200 μL of 0.5% polyethyleneimine (PEI) at room temperature for
2–3 h. The PEI solution was removed by a vacuum pump and the plate
was washed two times with 280 μL of Wash buffer. 120 μL of each
sample was added to the filter plate and the liquid was removed by
vacuum. The plate was washed 4 times with 200 μL of Wash buffer and
the filters were transferred into a 96-well Isoplate (PerkinElmer). The
filters were dried for 1 h at 65 °C, incubated overnight with 200 μL of
Optiphase Supermix (PerkinElmer) at room temperature and the
radioactivity was measured in a liquid scintillation counter
(PerkinElmer Microbeta 1450 plus). The concentration of ligand-bound
receptor was calculated according to reference filters with a known
concentration of hot ligand. The number of receptors per cells were
estimated from the OD600, assuming that 1 × 10
9 cells per mL refer to
an OD600 of 1.
To determine the Kd values, the incubation was performed with
binding buffers containing different concentrations of 3H-prazosin
(0.01–20 nM). The resuspended cells were added to an OD600 of 0.02
for the stabilized receptor mutants and to 0.2 for the WT receptor. The
calculations were performed using R version 3.3.3. Expected back-
ground signals, as measured by competition assays, were estimated by
linear regression with the intercept set to zero, and were subtracted
from the signal of the samples. Reference samples were used to calcu-
late a standard curve to correlate cpm/fmol by linear regression with
the intercept set to zero. Kd values were estimated using a non-linear
least squares approach using the following model derived from the Kd
definition:
= ∙ +Y B X K X( )/( )max d
Bmax (total concentration of receptor) and Kd were optimized to fit the
curve. Y is the concentration of bound ligand and X is the concentration
of free ligand, calculated by subtracting Y from the total ligand con-
centration.
4.8. CPM assay
The purified receptor in DDM/CHS was diluted to a final con-
centration of 1–2 μM in CPM dilution buffer (10 mM HEPES pH 7.5,
100 mM NaCl, 10% glycerol, 0.025% (w/v) DDM, 0.005% (w/v) CHS),
20 μM prazosin). The fluorescent dye 7-diethylamino-3-(4-
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maleimidophenyl)-4-methylcoumarin (CPM, Sigma), dissolved to
10 mM in DMSO, was diluted 40-fold to 250 μM with CPM dilution
buffer and was kept on ice and in the dark until use.
The diluted CPM dye was added to the receptor sample to a final
concentration of 25 μM. 20 μL of the mixture was transferred into a 96-
well plate for an Agilent MX3005p qPCR reader, sealed with adhesive
foil and incubated for 15 min at 25 °C. Each experiment was measured
as a triplicate. The fluorescence signal was monitored (excitation
387 nm, emission 463 nm) while increasing the temperature by 2 °C per
min from 25 °C to 95 °C.
4.9. SEC thermostability assay
The receptor was concentrated to approximately 2–3 mg/mL and
100–200 μL were filled into a 1.5 mL screw cap tube. The tube was
sealed tightly with parafilm and put in a 5 mL Eppendorf tube filled
with 100 μL water, to minimize evaporation. After incubation in an
Eppendorf thermoshaker at 700 rpm or in a Binder incubator, ag-
gregates were removed by spinning for 5 min at maximum speed in an
Eppendorf MiniSpin. 13 μL of the supernatant was filled into a 2 mL
screw cap glass vial with conical bottom and loaded with an Agilent
1260 Infinity HPLC system onto a Superdex 200 increase 10/150
column. Additionally, a Wyatt miniDAWN TREOS detector and a
Shodex RI-101 detector were connected to the system. The chromato-
graphy run was monitored with Agilent ChemStation software and
Astra software from Wyatt, collecting data for UV at 280 nm and
340 nm, refractive index and multiangle light scattering. The protein
could be followed at 280 nm, the presence of prazosin could be mea-
sured at 340 nm and the refractive index was used as a quality control
on the buffer salt peak to see if the sample might have been con-
centrated through evaporation.
4.10. SEC-MALS measurements
The SEC-MALS measurements were performed on a Superdex 200
Increase 10/300 column on an Agilent 1260 Inifinity HPLC system with
a Wyatt miniDAWN TREOS and a Shodex RI-101 detector in 20 mM Na-
phosphate pH 7, 100 mM NaCl and 0.01% (w/v) LMNG or 0.05% (w/v)
DDM/0.005% (w/v) CHS. The measurement was carried out at room
temperature with a flow rate of 0.5 mL/min. The protein and detergent
masses were calculated with the Astra 6 program from Wyatt. The light
scattering detector miniDAWN TREOS was calibrated with toluene and
the refractive index detector Shodex RI-101 was calibrated manually
with a BSA run. The extinction coefficient of the protein was calculated
with the ExPASy ProtParam tool, and the standard dn/dc value for
proteins of 0.185 mL/g was used. For the detergents the dn/dc values
were measured by manually injecting 5 mL of a 0.1%, 0.2%, 0.3%,
0.4% and 0.5% (w/v) detergent solution in water into the Shodex RI-
101 detector. The dn/dc values were then calculated with the Astra 6
program from Wyatt. The detergents alone also absorb slightly at
280 nm, therefore an extinction coefficient of 0.012 mL/(mg·cm) was
empirically determined by analyzing the DDM/CHS micelle peak.
4.11. MS measurements
50 μL of 1–2 mg/mL receptor in LMNG was precipitated with TCA at
4 °C and was centrifuged at 12,000×g for 10 min. The supernatant was
discarded, and the pellet was washed twice with acetone at −20 °C.
The pellet was reconstituted in hexafluoroisopropanol (HFIP) with 1%
formic acid and diluted with HFIP/isopropanol/formic acid and ana-
lyzed by ESI-MS in a mass range between 50 and 5000 Da. The sam-
pling cone energy was set to 100–150 V. The m/z data were deconvo-
luted using MaxEnt1 with an output resolution of 1 Da.
4.12. NMR measurements
NMR measurements were performed on a Bruker Avance 700 MHz
spectrometer with a cryogenically cooled TXI probe head at the UZH.
Samples were concentrated to approximately 200–400 μM in 10 mM
Na-phosphate pH 7, 20 mM NaCl, 10% D2O, an excess of 85 μM pra-
zosin and a final concentration of approximately 0.6% LMNG. Fully
protonated and d42-LMNG (FG Reagents) were used for nitrogen and
carbon correlations, respectively. All proton chemical shifts were re-
ferenced to the water line at 4.48 ppm at 47 °C, from which the nitrogen
and carbon scales were derived indirectly by using the conversion
factors of 0.10132900 (15N) and 0.25144954 (13C). Experiments were
recorded with the Bruker standard pulse sequences using sensitivity-
enhanced [15N,1H]-TROSY and [13C,1H]-HSQC spectra. Spectra were
processed and analyzed with TopSpin 4.0.
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